日本的新药开发战略:在准则遵守方面提供灵活性
Mihoko Kobayashi1,2, Mamoru Narukawa1
1Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Clinical pharmacology and therapeutics
|October 3, 2024
概括
日本 日本 日本 日本 日本.
科学领域:
- 制药发展 制药发展
- 监管科学 监管科学
- 临床试验 临床试验
背景情况:
- 一个"药物滞后"现象,称为"药物损失",正在日本出现,在日本,在其他地方批准的药物没有启动开发.
- 这种滞后可能源于日本指导方针要求本地临床试验数据,这给外国生物制药公司带来了挑战.
- 了解遵守这些准则对于解决开发延迟至关重要.
研究的目的:
- 调查日本对新药应用的准则遵守情况.
- 确定影响外国药物开发商临床数据要求灵活性的因素.
- 为在日本缓解药物滞后的战略提供信息.
主要方法:
- 对日本批准的159种药物的临床数据包的分析 (2019年4月 - 2024年3月).
- 对来自日本参与者的药理动力学 (PK) 和疗效/安全数据的检查.
- 识别灵活的开发方法和相关的药物特征.
主要成果:
- 几乎所有批准的药物都包括日本PK和疗效/安全数据.
- 观察到灵活的方法:没有日本剂量反应数据 (39.6%),III期数据 (35.2%) 和后期PK数据 (43.0%).
- 生物制品,孤儿药物,抗原塑料和原始公司与灵活性有显著的关联.
结论:
- 虽然一般包括日本数据,但在特定的试验阶段和数据类型中存在灵活性.
- 药物类型和名称等因素会影响灵活性程度.
- 这些发现可以指导外国公司制定战略,以加快日本的药物开发.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Control Governance: Regulatory Bodies and Their Impact
145
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
145
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
